StatLab Medical Products

StatLab operates as a manufacturer and distributor of medical laboratory supplies, not as a family office allocating capital to external funds. The firm acquires complementary histology and cytology product lines and integrates them into its own manufacturing and distribution network, making it an operational holding company rather than an investment vehicle.

StatLab's catalog includes microscope slides, tissue embedding media such as paraffin waxes, immunohistochemistry reagents, stains, and cassette printers used in histology and cytology workflows. These consumables support clinical pathology labs, research hospitals, and reference laboratories.

The firm grows through acquisition of smaller manufacturers and distributors in the diagnostics consumables space. A recent example is the 2019 purchase of Cancer Diagnostics, which added proprietary stains and control slides to StatLab's existing product portfolio. The acquired companies are integrated into StatLab's operational footprint rather than held as passive investments.

CEO Sue Chang leads the firm's overall strategy, including acquisition decisions. Because StatLab is an operating company and not a fund manager or family office, acquisitions are conducted as corporate transactions to expand manufacturing capability, geographic reach, or product lines, rather than as portfolio investments requiring an investment committee.

Public record does not confirm the firm's ownership structure. StatLab does not disclose whether it is privately held by a family or founder, backed by a private equity sponsor, or structured as an independent operating company. No regulatory filings specifying beneficial ownership are readily available.